Detection of liver cancer serum markers and molecular analysis of metabolites based on electrochemical sensors: Combined targeted immunotherapy | Synapse
March 3, 2026
Detection of liver cancer serum markers and molecular analysis of metabolites based on electrochemical sensors: Combined targeted immunotherapy
Key Points
Liver cancer serum markers show distinct profiles, indicating their utility in diagnosis and monitoring.
Key metrics indicate that the specificity of electrochemical sensors reaches 90% in detecting these markers.
Assessment using electrochemical sensors enables molecular analysis of metabolites linked to liver cancer progression.
Findings highlight the promise of targeted immunotherapy in improving patient outcomes, though further validation is required.